The global Sickle Cell Disease (SCD) Treatment Market, valued at US$ 2.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 18.5% from 2024 to 2034, surpassing US$ 17.7 billion by 2034. SCD, a hereditary blood disorder c...
No responses yet.